Jefferies Group's ETRA Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 2.24 M shares of Electra Therapeutics, Inc. (ETRA) worth $25.25 M, representing 0.19% of the portfolio. First purchased in 2026-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Jefferies Group has initiated a new position in ETRA, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Electra Therapeutics (ETRA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Electra Therapeutics (ETRA) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +2.24 M | New Buy | 2.24 M | $11.25 |
Jefferies Group's Electra Therapeutics Investment FAQs
Jefferies Group first purchased Electra Therapeutics, Inc. (ETRA) in Q3 2026, acquiring 2,244,333 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Electra Therapeutics, Inc. (ETRA) for 1 quarters since Q3 2026.
Jefferies Group's largest addition to Electra Therapeutics, Inc. (ETRA) was in Q3 2026, adding 2,244,333 shares worth $25.25 M.
According to the latest 13F filing for Q3 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 2,244,333 shares of Electra Therapeutics, Inc. (ETRA), valued at approximately $25.25 M.
As of the Q3 2026 filing, Electra Therapeutics, Inc. (ETRA) represents approximately 0.19% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Electra Therapeutics, Inc. (ETRA) was 2,244,333 shares, as reported at the end of Q3 2026.